Both in Biotechnology
Halozyme Therapeutics vs Bio-Techne
Over the past year HALO returned +94.3% and TECH returned +18.6%; their daily moves had a correlation of 0.20.
HALO +94.3% TECH +18.6%Growth of $1, one year, split-adjusted
| Metric | HALO | TECH |
|---|---|---|
| Price | $128.62 | $72.66 |
| Market cap | $14.60B | $11.41B |
| Today | −0.26% | −0.01% |
| 1 month | +18.8% | +0.1% |
| 6 months | +95.3% | +28.2% |
| Year to date | +91.1% | +23.6% |
| 1 year | +97.3% | +16.1% |
| Revenue growth (YoY) | +47.7% | +1.3% |
| Gross margin | 83.5% | 65.8% |
| Net margin | 47.8% | 17.0% |
| P/E (TTM) | 35.3× | 62.7× |
| Price / sales | 8.8× | 9.4× |
| Net cash | -$1.92B | $64.7M |
| Dividend yield | — | 0.44% |
| Volatility (60d) | 27.8% | 2.2% |
| Short % of float | 12.4% | 4.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).